A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen

Archives of Virology

Volumn 153, Issue 6, 2008, Pages 1021-1029

  Wei, S H ^a   Yin, W ^a   An, Q X ^a   Lei, Y F ^a   Hu, X B ^a   Yang, J ^a   Lu, X ^a   Zhang, H ^a   Xu, Z K ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; GLYCOPROTEIN E2, HEPATITIS C VIRUS; HEPATITIS C ANTIBODY; HEPATITIS VACCINE; HLA A2 ANTIGEN; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CELL DIVISION; CYTOTOXICITY TEST; GENE VECTOR; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MOLECULAR GENETICS; MOUSE; MYCOBACTERIUM BOVIS; SPLEEN; TRANSGENIC MOUSE; VACCINIA; VACCINIA VIRUS;

AMINO ACID SEQUENCE; ANIMALS; CELL DIVISION; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HLA-A2 ANTIGEN; IMMUNIZATION; LYMPHOCYTES; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; RECOMBINANT PROTEINS; SPLEEN; VACCINES, SYNTHETIC; VACCINIA; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; MUS MUSCULUS; MYCOBACTERIUM BOVIS BCG; VACCINIA VIRUS;

EID: 44449157563     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-008-0082-1     Document Type: Article

References (41)

1. Williams R (2006) Global challenges in liver disease. Hepatology 44(3):521-526
2. Poynard T, Yuen MF, Ratziu V, Lai CL (2006) Viral hepatitis C. Lancet 362(9401):2095-3000
3. Shiina M, Rehermann B (2006) Hepatitis C vaccines: inducing and challenging memory T cell. Hepatology 43(6):1395-1398
4. Chisari FV (2005) Unscrambling hepatitis C virus-host interactions. Nature 436(7053):930-932
5. Gruner NH, Gerlach TJ, Jung MC, Diepolder HM, Schirren CA, Schraut WW (2000) Association of hepatitis C virus-specific CD8(+) T cells with viral clearance in acute hepatitis C. J Inf Dis 181:1528-1536
6. Lechner F, Wong DKH, Dunber PR, Chapman R, Chung RT, Dohrenwend P (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512
7. Ward S, Lauer G, Isba R, Walker B, Klenerman P (2002) Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol 128(2):195-203
8. Acosta-Rivero N, Dueñas-Carrera S, Alvarez-Lajonchere L (2004) HCV core protein-expressing DNA vaccine induces a strong class I-binding peptide DTH response in mice. Biochem Biophys Res Commun 314:781-786
9. Puntoriero G, Meola A, Lahm A (1998) Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J 17:3521-3533
10. Zhang XX, Deng Q, Zhang SY (2003) Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library. J Med Virol 71:511-517
11. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191(9):1499-1512
12. Cohen J (1999) The scientific challenge of hepatitis C virus. Science 285(5424):26-30
13. Houghton M, Weiner A, Han J, Kuo G, Choo QL (1991) Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14(2):381-388
14. +-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 76:6104-6113
15. Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T (2003) Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Human Immunol 64(2):224-230
16. Arribillaga L, de Cerio AL, Sarobe P, Casares N, Gorraiz M, Vales A, Bruna-Romero O, Borrás-Cuesta F, Paranhos-Baccala G, Prieto J, Ruiz J, Lasarte JJ (2002) Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Vaccine 21(3-4):202-210
17. Racanelli V, Behrens SE, Aliberti J, Rehermann B (2004) Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8_ T cells and antiviral immunity. Immunity 20:47-58
18. Abomoelak B, Huygen K, Kremer L, Turneer M, Locht C (1999) Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guerin producing a pertussis toxin-tetanus toxin hybrid protein. Infect Immun 67(10):5100-5105
19. Leung NJ, Aldovini A, Yong R, Jarvis MA, Smith JM, Meyer D, Anderson DE, Carlos MP, Gardner MB, Torres JV (2000) The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env and Nef proteins. Virology 268(1):94-103
20. Uno-Furuta S, Matsuo K, Tamaki S, Takamura S, Kamei A, Kuromatsu I, Kaito M, Matsuura Y, Miyamura T, Adachi Y, Yasutomi Y (2003) Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice. Vaccine 21(23):3149-3156
21. Shi CH, Xu ZK, Zhu DS, Li Y, Bai YL, Xue Y (2005) Screening and construction of recombinant BCG stains expressing the Ag85B-ESAT6 fusion protein. Zhonghua Jie He Hu Xi Za Zhi 28(4):254-257
22. Rezende CA, De Moraes MT, De Souza Matos DC, McIntoch D, Armoa GR (2005) Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens. J Virol Methods 125(1):1-9
23. O'Gaora P, Barnini S, Hayward C, Filley E, Rook G, Young D, Thole J (1997) Mycobacteria as immunogens: development of expression vectors for use in multiple mycobacterial species. Med Princ Pract 6:91-96
24. Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X (2007) Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. J Virol Methods 141(1):41-48
25. Snapper SB, Lugosi L, Jekkel A, Melton RE, Kieser T, Bloom BR, Jacobs WR Jr (1988) Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc Natl Acad Sci USA 85(18):6987-6991
26. Wei SH, Yin W, Hu XB, Lei YF, Yang J, Lu X, Sun MN, Xue ZK (2006) Expression of HCV multi-epitope gene in E.coli and analysis of its immunological characteristics. Immunol J 22:652-655
27. Newberg MH, Smith DH, Haertel SB, Vining DR, Lacy E, Engelhard VH (1996) Importance of MHC class 1 α2 and α3 domains in the recognition of self and non-self MHC molecules. J Immunol 569:2473-2480
28. + T Cell Peptide Epitope of Vaccinia and Variola Viruses. J Virol 78(13):7052-7060
29. Davis GL, Albright JE, Cook SF, Rosenberg DM (2003) Projecting future complications of chronic hepatitis C in the United States. Liver Transp l 9(4):331-338
30. + T cells in HLA-A2.1.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins. Vaccine 23(1):58-68
31. Matsui M, Moriya O, Abdel-Aziz N, Matsuura Y, Miyamura T, Akatsuka T (2002) Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus. Vaccine 21(3-4):211-220
32. Brinster C, Chen M, Boucreux D, Boucreux D, Paranhos-Baccala G, Liljestrom P, Lemmonier F, Inchauspe G (2002) Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles. J Gen Virol 83(Pt2):369-381
33. Yu H, Huang H, Xiang J, Babiuk LA, den Hurk S (2006) Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. J Gen Virol 87(1):1-10
34. Dustin LB, Rice CM (2007) Flying Under the Radar: The Immunobiology of Hepatitis C. Annu Rev Immunol 25:71-99
35. Thimme R, Lohmann V, Wdber F (2006) A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res 29:129-141
36. Livingston BD, Newman M, Crimi C, McKinney D, Chesnut R, Sette A (2001). Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine (19): 4652-4660
37. Velders MP, Weijzen S, Eiben GL, Elmishad AG, Kloetzel PM, Higgins T, Ciccarelli RB, Evans M, Man S, Smith L, Kast WM (2001) Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine1. J Immunol 166(9):5366-5373
38. Isbilka GY, Fikes J, Hermanson G et al (1999) Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol 162(7):3915-3925
39. Doan T, Herd K, Ramshaw I, Thomson S, Tindle RW (2005) A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumou. Cancer Immunol Immunother 54(2):157-171
40. +cytotoxic T cslls against both immunodominant and cryptic epitopes. Vaccine 23:1085-1091
41. Bao L, Chen W, Zhang H et al (2003) Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis Bacillus Calmette-Guerin strains expressing the antigen ESAT6 from Mycobacterium tuberculosis. Infect Immun 71(4):1656-1661